Miwa K, Miyagi Y, Asanoi H, Fujita M, Sasayama S
Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.
Jpn Circ J. 1993 Aug;57(8):775-80. doi: 10.1253/jcj.57.775.
Monitoring the current smoking status by an objective method may augment the effects of smoking cessation instruction. To quantitatively evaluate smoking status and its modification by smoking cessation instruction, urinary cotinine, a major metabolite of nicotine, was measured by radioimmunoassay in 64 patients with a smoking habit before and during smoking cessation instruction. Urinary cotinine levels were used to discriminate between smokers and nonsmokers (with 50 ng/ml used as a threshold). In 49 patients who claimed to have stopped smoking, urinary cotinine concentrations 1 month after instruction indicated that only 30 (61%) of them had actually stopped (before: 243 +/- 104, after: 1 +/- 3 ng/ml) (mean +/- standard deviation). In the remaining 15 patients who failed to stop smoking while reporting a reduction of cigarette consumption (before: 27 +/- 12, after: 7 +/- 5/day), there was no appreciable reduction in urinary cotinine levels (before: 298 +/- 140, after: 229 +/- 171 ng/ml). When the patients who had failed to stop smoking again received intensive smoking cessation instruction, the success rate increased from 47% (30/64) to 69% (44/64) (p < 0.05). Thus, urinary cotinine measurement may provide a useful and quantitative method for monitoring actual smoking habits and thus augment the efficacy of smoking cessation educational programs.
采用客观方法监测当前吸烟状况可能会增强戒烟指导的效果。为了定量评估吸烟状况及其因戒烟指导而发生的改变,对64名有吸烟习惯的患者在戒烟指导前和指导期间,通过放射免疫分析法测定了尼古丁的主要代谢产物尿可替宁。尿可替宁水平用于区分吸烟者和非吸烟者(以50纳克/毫升作为阈值)。在49名声称已戒烟的患者中,指导1个月后的尿可替宁浓度表明,其中只有30名(61%)实际已戒烟(之前:243±104,之后:1±3纳克/毫升)(均值±标准差)。在其余15名虽报告减少了香烟消费量但未成功戒烟的患者中(之前:27±12,之后:7±5支/天),尿可替宁水平没有明显降低(之前:298±140,之后:229±171纳克/毫升)。当再次接受强化戒烟指导后,未成功戒烟的患者成功率从47%(30/64)提高到了69%(44/64)(p<0.05)。因此,测定尿可替宁可能为监测实际吸烟习惯提供一种有用的定量方法,从而提高戒烟教育项目的效果。